Cite

HARVARD Citation

    Wollenberg, A. et al. (2020). 评估接受 Dupilumab 治疗的中度至重度特应性皮炎患者进行常规安全性检测的必要性. British journal of dermatology. p. e198. [Online]. 
  
Back to record